Abnormally low prolactin levels in schizophrenia patients after switching to aripiprazole in a randomized trial: a biomarker for rebound in psychotic symptoms?
Ya-Wen JenTzung-Jeng HwangHung-Yu ChanMing H HsiehChen-Chung LiuChih-Min LiuHai-Gwo HwuChing-Hua KuoYi-Ting LinYi-Ling ChienWei J ChenPublished in: BMC psychiatry (2020)
NCT00545467 ; Date of registration: 17/10/2007.